MC1R and vitiligo: Apart from their clinically unequivocal pigmentation effect, α‐MSH and agonists that activate the melanocortin‐1 receptor (MC1R) also have cytoprotective, immunomodulatory, and indirect antioxidative effects184, 185, 186 that are of interest for the treatment of vitiligo.